Abstract
Using MRI, the main aim was to (1) map the pattern of muscle involvement by assessing fat fraction and (2) investigate frequency of target and sandwich signs in 42 muscles of patients with Bethlem myopathy (BM). Fifteen BM patients were included. Results were compared to findings in 8 healthy controls and 50 patients with four other types of muscular dystrophies. All muscles, except one, showed higher fat fraction in BM patients vs healthy controls (p < 0.05) with an overall proximal muscle affection, resembling a limb girdle-like pattern. In moderate patients, the specificity was 90% for the sandwich sign and 98% for the target sign. Sensitivity for both signs was 100%. Twelve BM patients had sandwich sign in other muscles than the vastus lateralis. Muscle strength correlated with fat fraction. Mean fat fraction in the psoas major was 39% in BM patients, which was considerably higher than in 3 of the 4 muscular dystrophy control diseases. The presence of signs in conjunction with severe affection of the psoas major muscle can serve as a diagnostic tool in BM. The high level of STIR lesions in muscles of BM patients warrants further investigations.
Similar content being viewed by others
Availability of data and material
The data that support the findings of this study are available from the corresponding author, R Salim, upon reasonable request.
References
Bönnemann CG (2011) The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy. Handb Clin Neurol 101:81–96. https://doi.org/10.1016/B978-0-08-045031-5.00005-0
Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH et al (2005) Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet 42(2):108–120
Miscione MT, Bruno F, Ripamonti C, Nervuti G, Orsini R, Faldini C et al (2013) Body composition, muscle strength, and physical function of patient with Bethlem myopathy and Ullrich congenital muscular dystrophy. Sci World J. https://doi.org/10.1155/2013/152684
Jöbsis GJ, Boers JM, Barth PG, de Visser M (1999) Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures. Brain 122(Pt4):649–655
Yonekawa T, Nishino I (2015) Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatry 86(3):280–287. https://doi.org/10.1136/jnnp-2013-307052(Epub 2014)
Fu J, Zheng YM, Jin SQ, Yi JF, Liu XJ, Lyn H et al (2016) Target” and “sandwich” signs in thigh muscles have high diagnostic values for collagen VI-related myopathies. Chin Med J (Engl) 129(15):1811–1816. https://doi.org/10.4103/0366-6999.186638
Mercuri E, Lampe A, Allsop J, Knight R, Pane M, Kinali M et al (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord 15(4):303–310
Deconinck N, Richard P, Allamand V, Behin A, Lafôret P, Ferreiro A, de Becdelievre A et al (2015) Bethlem myopathy: long term follow up identifies COL6 mutation predicting severe clinical evolution. J Neurol Neurosurg Psychiatry 86(12):1337–1346. https://doi.org/10.1136/jnnp-2013-307245(Epub 2014)
Dahlqvist JR, Vissing CR, Hedermann G, Thomsen C, Vissing J (2017) Fat replacement of paraspinal muscles with aging in healthy adults. Med Sci Sports Exerc 49(3):595–601. https://doi.org/10.1249/MSS.0000000000001119
Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O et al (2008) Reliability and validity of the medical research council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 40(8):665–671. https://doi.org/10.2340/16501977-0235
Dahlqvist JR, Vissing CR, Thomsen C, Vissing J (2014) Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology 83(13):1178–1183. https://doi.org/10.1212/WNL.0000000000000828(Epub 2014)
Diaz-Manera J, Llauger J, Gallardo E, Illa I (2015) Muscle MRI in muscular dystrophies. Acta Myol. 34(2–3):95–108
Dahlqvist JR, Oestergaard ST, Poulsen NS, Thomsen C, Vissing J et al (2019) Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology 92(6):e548–e559. https://doi.org/10.1212/WNL.0000000000006887(Epub 2019)
Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F et al (2007) Muscle MRI in inherited neuromuscular disorders: Past, present, and future. J Magn Reson Imaging 25(2):433–440
Barp A, Laforet P, Bello L et al (2020) European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A). J Neurol 267:45–56
Fortin M, Videman T, Gibbons LE, Battié MC (2014) Paraspinal muscle morphology and composition: a 15-year longitudinal magnetic resonance imaging study. Med Sci Sports Exerc 46(5):893–901. https://doi.org/10.1249/MSS.0000000000000179
Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064
Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T et al (2013) Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS ONE 8(8):e70993. https://doi.org/10.1371/journal.pone.0070993(eCollection 2013)
Olesen DB, Gideon P, Jeppesen TD, Vissing J (2006) Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 253(11):1437–1441 (Epub 2006)
Polavarapu K, Manjunath M, Preethish-Kumar V, Sekar D, Vengalil S, Thomas P et al (2016) Muscle MRI in duchenne muscular dystrophy: evidence of a distinctive pattern. Neuromuscul Disord 26(11):768–774. https://doi.org/10.1016/j.nmd.2016.09.002
Ferguson MR, Poliachik SL, Budech CB, Gove NE, Carter GT, Wang LH et al (2018) MRI change metrics of facioscapulohumeral muscular dystrophy: STIR and T1. Muscle Nerve 57(6):905–912. https://doi.org/10.1002/mus.26038
Friedman SD, Poliachik SL, Otto RK, Carter GT, Budech CB, Bird TD et al (2014) Longitudinal features of STIR bright signal in FSHD. Muscle Nerve 49(2):257–260
Falzarano MS, Scotton C, Passarelli C, Ferlini A (2015) Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20(10):18168–18184. https://doi.org/10.3390/molecules201018168
Hightower RM, Alexander MS (2018) Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies. Muscle Nerve 57(1):6–15. https://doi.org/10.1002/mus.25953(Epub 2017)
Acknowledgements
The authors thank Christian Hammer Nielsen, radiologist, Department of Diagnostic Radiology, Rigshospitalet, for his helpful advice and supervision during the first MRI sessions.
Funding
This work was supported by A.P. Møller Fonden, Copenhagen, Denmark.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethics approval
The study was approved by the Danish National Committee on Health Research. Ethics (approval number H-18023049) and the Danish Data Protection agency and registered at https://www.clinicaltrials.gov (NCT03693898).
Informed consent
All participants gave their informed consent prior to their inclusion in the study.
Rights and permissions
About this article
Cite this article
Salim, R., Dahlqvist, J.R., Khawajazada, T. et al. Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy. J Neurol 267, 2432–2442 (2020). https://doi.org/10.1007/s00415-020-09860-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-020-09860-x